| 【Company Research】FriendTimes Inc. (6820 HK) – Investing in R&D to deliver premium games |
| 【Fixed Income Research】1H2021 “Three Red Lines” Update |
| 【Company Research】Jinxin Fertility (1951 HK) – Better-than-expected recovery from COVID-19 impact |
| 【Company Research】Venus Medtech (Hangzhou) Inc. (2500 HK) – Maintained dominant position in TAVR market |
| 【Company Research】I-Mab BioPharma (IMAB US) – Diversified and highly-differentiated pipeline |
| 【公司研究】廣汽集團 (2238 HK) – 埃安混改有序推進，電池技術逐步落地 |
| 【Company Research】China Pacific Insurance (2601 HK) – Re-energizing agency force |
| 【Company Research】JNBY Design (3306 HK) – Conservative guidance after a strong result |
| 【Company Research】JS Global Lifestyle (1691 HK) – Rapid growth and stable margin are achievable |
| 【公司研究】隆基股份 - A (601012 CH) – 無懼風浪，穩舵前行 |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
